Clinical Takeaways & Management Implications

03 Nov 2026 0 comments

Dr. Muley synthesizes the data: durable response at 52 weeks in both AChR+ and MuSK+ patients with no new safety signals.

Source: NeurologyLive Published 02 Nov 2026 Imported 02 Nov 2026 Relevancy: Not reviewed

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.